|
|
|
|
|
|
|
|
|
|
|
What evidence she holds on the dependence risk of Zoplicone in clinical usage; what representations have been made by DH since 1989 to the manufacturers of Zimovane, in respect of their claims that there is no evidence of dependence in clinical use; and what was the outcome and what action she proposes to take against the manufacturers of Zimovane in respect of their claims that there is no evidence of depedence in clinical use. |
|
|
|
Dept of Health |
|
http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_407461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|